CANCER 2026 Murugan Kalimutho
Mater Research Institute, QLD, Australia
Presentations this author is a contributor to:
Targeting a redox protein, thioredoxin reductase 3, sensitizes triple-negative breast cancers to EGFR inhibitors. (#242)
5:35 PM
Prahlad Raninga
Poster Session 2